Type 2 Diabetes (T2D) | Norton Children's

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Indication: Type 2 Diabetes (T2D)

Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes

Sub-indication: Type 2 Diabetes (T2D)

Study Type: Drug Study

Principal Investigator: Kupper Wintergerst, M.D.
Norton Children's Endocrinology, affiliated with the UofL School of Medicine

Sponsor: Sponsor: Novo Nordisk, Inc.

Search our entire site.

As we continue to seek to protect our patients, face masks are required in patient settings such as hospitals, doctors’ offices and medical centers.

Type 2 Diabetes (T2D) Clinical Trial